1. Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene

   • Hidetsugu Kawai
   • Hiromichi Matsushita
   • Kiyoshi Ando

   Images in Hematology 09 May 2018 Pages: 1 - 2

   

2. IgM k multiple myeloma with monoclonal surface immunoglobulin expression

   • Kamel Laribi
   • Mustafa Alani
   • Pierre Lemaire

   Images in Hematology 19 May 2018 Pages: 3 - 4

   

3. β-Thalassemia intermedia: a comprehensive overview and novel approaches

   • Chingiz Asadov
   • Zohra Alimirzoeva
   • Jeyhun Mammadov

   Review Article 29 January 2018 Pages: 5 - 21

   

4. Perioperative safety and hemostatic efficacy of Advate^® in patients with hemophilia A in a postmarketing surveillance in Japan

   • Keiji Nogami
   • Hideyuki Takedani
   • Akira Shirahata

   Original Article 28 March 2018 Pages: 22 - 29

5. PAS positivity of erythroid precursor cells is associated with a poor prognosis in newly diagnosed myelodysplastic syndrome patients

   • Kenta Masuda
   • Shuichi Shiga
   • Yasuhiko Kamikubo

   Original Article 29 March 2018 Pages: 30 - 38

   

6. Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial

   • Atsushi Isoda
   • Kayoko Murayama
   • For the Kanshinetsu Multiple Myeloma Study Group

   Original Article 28 March 2018 Pages: 39 - 46

   

7. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia

   • Junichi Watanabe
   • Ken Sato
   • Fumihiko Kimura

   Original Article 29 March 2018 Pages: 47 - 57

   

8. Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese population

   • Keiji Kurata
   • Kimikazu Yakushijin
   • Hironobu Minami

   Original Article 22 March 2018 Pages: 58 - 65

   

9. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation

   • Koji Kawaguchi
   • Katsutsugu Umeda
   • Souichi Adachi

   Original Article 26 March 2018 Pages: 66 - 75

   

10. T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia

    • Hideki Sano
    • Kazuhiro Mochizuki
    • Atsushi Kikuta

    Original Article 05 March 2018 Pages: 76 - 84

    

11. Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia

    • Hirozumi Sano
    • Ryoji Kobayashi
    • Kunihiko Kobayashi

    Original Article 21 March 2018 Pages: 85 - 90

    

12. Nationwide survey of therapy-related leukemia in childhood in Japan

    • Toshihiko Imamura
    • Takashi Taga
    • Japanese Society of Pediatric Hematology Oncology (JSPHO)

    Original Article 24 March 2018 Pages: 91 - 97

13. Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group (TCCSG) Study L04-16

    • Hiroyuki Takahashi
    • Ryosuke Kajiwara
    • Akira Ohara

    Original Article 27 March 2018 Pages: 98 - 108

    

14. A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag

    • Naruko Suzuki
    • Junji Hiraga
    • Yoshitoyo Kagami

    Case Report 29 November 2017 Pages: 109 - 111

    

15. Systemic Epstein–Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings

    • Sachie Wada
    • Takayuki Suzuki
    • Seiichiro Shimizu

    Case Report 07 December 2017 Pages: 112 - 117